Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.02 | 38.11 |
| PEG Ratio (TTM) | 0.00 | -1.55 |
| P/S Ratio (TTM) | 0.01 | 6.86 |
| P/B Ratio (TTM) | 0.00 | 1.35 |
| P/FCF Ratio (TTM) | -0.12 | 1.69 |
| Price to 5YR AVG Earnings Ratio | -1.04 | -14.07 |
| Price to 5YR AVG FCF Ratio | 0.07 | 7.74 |
Profitability (10%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -2.66% | 316.96% |
| ROE (TTM) | -11.03% | 6.20% |
| Net Profit Margin (TTM) | -9.57% | 28.09% |
| ROIC 5YR AVG | 6.07% | 4.75% |
Growth (15%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -112.46% | -2,448.98% | -1,501.77% |
| Revenue | 1.29% | -29.98% | 188.90% |
| Net Income | -123.88% | -2,553.06% | -1,567.09% |
| Cash Flow | -4.50% | -23.51% | 13.76% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.03 | 8.90 |
| Quick Ratio (TTM) | 0.12 | 11.31 |
| D/E Ratio (TTM) | 2.07 | 1.03 |
| Interest Coverage (TTM) | 0.06 | -21.30 |
| Piotroski F-Score | 5 | 5 |
| Altman Z-Score | N/A | 1.21 |
| LTL to 5YR AVG FCF | 4.46 | 7.03 |
| Shares Outstanding Growth 5YR AVG | -5.37% | 27.06% |